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Abstract
Background: Efficient targeting to appropriate cell organelles is one of the bottlenecks for the
production of recombinant proteins in plant systems. A common practice is to use the native
secretory signal peptide of the heterologous protein to be produced. Though general features of
secretion signals are conserved between plants and animals, the broad sequence variability among
signal peptides suggests differing efficiency of signal peptide recognition.
Results:  Aiming to improve secretion in moss bioreactors, we quantitatively compared the
efficiency of two human signal peptides and six signals from recently isolated moss (Physcomitrella
patens) proteins. We therefore used fusions of the different signals to heterologous reporter
sequences for transient transfection of moss cells and measured the extra- and intracellular
accumulation of the recombinant proteins rhVEGF and GST, respectively. Our data demonstrates
an up to fivefold higher secretion efficiency with endogenous moss signals compared to the two
utilised human signal peptides.
Conclusion: From the distribution of extra- and intracellular recombinant proteins, we suggest
translational inhibition during the signal recognition particle-cycle (SRP-cycle) as the most probable
of several possible explanations for the decreased extracellular accumulation with the human
signals. In this work, we report on the supremacy of moss secretion signals over the utilised
heterologous ones within the moss-bioreactor system. Though the molecular details of this effect
remain to be elucidated, our results will contribute to the improvement of molecular farming
systems.
Background
The product range for recombinant biopharmaceuticals
includes relatively simple proteins, for example insulin,
and ends with candidates that require extensive secondary
modification like erythropoietin or coagulation factor IX
[1,2]. Commercial-scale production of proteins (molecu-
lar farming) nowadays is mainly performed with bacteria
or mammalian cell-culture systems [1,3,4]. Bacterial pro-
Published: 07 November 2005
BMC Biotechnology 2005, 5:30 doi:10.1186/1472-6750-5-30
Received: 20 May 2005
Accepted: 07 November 2005
This article is available from: http://www.biomedcentral.com/1472-6750/5/30
© 2005 Schaaf et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Biotechnology 2005, 5:30 http://www.biomedcentral.com/1472-6750/5/30
Page 2 of 11
(page number not for citation purposes)
duction systems are highly efficient and well established
for the production of comparably simple proteins but
they come to their limits if complex posttranslational
processing is required. One major problem is the absence
of protein glycosylation in prokaryotes. Mammalian cell
lines, on the other hand, perform human-like posttransla-
tional modifications and offer a high product quality but
hold risks of product contamination and high overall pro-
duction costs (e.g. [5]).
Plants have emerged as a safe and cost-effective alternative
to the traditional systems (e.g. [6,7]). They synthesize pro-
teins with correct assemblage and the posttranslational
modifications of higher eukaryotes. In contrast to micro-
bial systems, glycosylated plant proteins carry complex-
type glycans with the same core structure as human glyco-
proteins. The glycosylation pattern of plant proteins, how-
ever, differs from that in humans concerning two residues
linked to the core structure as well as terminal sugar moi-
eties [2,8]. The adaptation of the plant glycan pattern to its
human counterpart (humanisation) poses a challenge for
the implementation of plant systems with regard to the
production of recombinant pharmaceutical proteins [9]
as differences in the glycan structure could substantially
alter protein characteristics and even act immunogenically
in patients [10-13].
The moss Physcomitrella patens is the only known plant in
which homologous recombination occurs in a frequency
that allows its application as an engineering tool for tar-
geted knock out and gene replacement. With this tech-
nique a humanisation of the moss glycosylation pattern
was performed recently [14,15]. Together with photoau-
totrophic growth in bioreactors these advantages make
Physcomitrella an ideal system for the production of plant-
made pharmaceuticals [16].
In molecular farming approaches, recombinant proteins,
which require correct posttranslational modifications, are
often targeted to the secretory pathway. This, on the one
hand, is due to the fact that enzymes responsible for vari-
ous modifications, e. g. glycosylation and protein trim-
ming, are located within the membranes of endoplasmic
reticulum (ER) and Golgi apparatus. On the other hand,
secretion of the protein of interest into the culture
medium separates it from the pool of intracellular pro-
teins and therefore drastically facilitates its purification
and reduces costs for downstream processing [1].
A common way to achieve secretion of recombinant pro-
teins is the utilisation of the native signal peptide, if any is
present. The mechanism of protein secretion depends on
the recognition of an N-terminal signal peptide and is
conserved among all eukaryotes [17]. Though the general
hydrophobic character of secretion signals is conserved
between plants and animals, they are not universally
interchangeable [18]. Additional features might contrib-
ute to the efficiency of signal peptide recognition [19]. In
order to establish moss as a production system for recom-
binant proteins, we intended to enrich our toolboxes with
a set of endogenous signal sequences from the moss. The
availability of Physcomitrella secretion signals gives us the
opportunity to secrete even proteins that are located
within the cytosol in their host organism and thus lack a
secretion signal.
Here, we describe the comparison of two heterologous
signal peptides from human origin, the vascular endothe-
lial growth factor (hVEGF) and the coagulation factor IX
(hFIX), respectively, in the moss. Evaluation of a heterol-
ogous signal and the signal peptide of Physcomitrella aspar-
tic proteinase PpAP1 [20] revealed better secretion of
recombinant hVEGF (rhVEGF) with the moss signal.
In addition, the secretion efficiency of five putative signal
peptides originating from recently isolated and identified
Physcomitrella extracellular proteins xyloglucan endotrans-
glycosylase/hydrolase (PpXTH1), pectin methylesterase
(PpPME1), fasciclin-like protein (PpFLP), carbonic anhy-
drase-like protein (PpCALP), and lipid-transfer protein
(PpLTP) (Tintelnot et al., manuscript in preparation) was
tested in comparison to the PpAP1 secretion signal. These
signal sequences were fused to hVEGF and amounts of
secreted rhVEGF were quantified by ELISA measurements.
All of the investigated moss signal peptides showed at
least comparable or even higher secretion efficiency than
the human signals. Besides, we underline the functional-
ity of a transient production technique, that allows the
fast production of recombinant proteins [21]. Within the
field of molecular farming these techniques are essential
for proof-of-concept studies prior to the establishment of
production lines.
Results
Efficiency of human secretion signals in Physcomitrella 
patens
In order to improve transient production and secretion of
pharmaceutically interesting proteins in the moss Phys-
comitrella patens, we first tested the efficiency of two
human signal peptides. These were derived from the
human blood clotting factor IX (hFIX) and the vascular
endothelial growth factor (hVEGF). The secretion signals
of both proteins, FSP and VSP, respectively, were tested
with hVEGF as a reporter gene. Physcomitrella protoplasts
were transiently transfected with the respective plasmids
followed by quantification of extra- and intracellular con-
centrations of the recombinant proteins by ELISA (Fig. 1).
Testing the hFIX signal peptide FSP, the moss cells
secreted on average 18.17 ng/ml recombinant hVEGF
(rhVEGF) to the culture supernatant, whereas the hVEGFBMC Biotechnology 2005, 5:30 http://www.biomedcentral.com/1472-6750/5/30
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signal VSP yielded a slightly higher average value (25.27
ng/ml). Comparison with intracellular concentrations of
rhVEGF proved that both heterologous signals from
human origin were quite effective in secreting the reporter
protein from moss cells.
Transient production of recombinant glutathione S-
transferase
Having proven the general functionality of heterologous
secretion signals we aimed to compare the efficiency of a
human and a moss signal peptide. We chose VSP that
secreted a slightly higher amount of the reporter protein,
and ASP, a moss signal sequence of the recently character-
ised aspartic proteinase PpAP1 [20]. The signal sequences
were fused to the cDNA of glutathione S-transferase (GST)
from Schistosoma japonicum, which served as a reporter
protein. Five days after transient transfection of moss cells,
reporter concentrations were quantified by ELISA (Fig. 2).
With the moss signal peptide ASP, the protoplasts secreted
between 14.11 and 24.33 ng/ml rGST into the culture
supernatant. On the contrary, the human signal peptide
yielded values in the range from 4.50 to 7.17 ng/ml.
Taken the means of these values, when using the moss sig-
nal peptide, the concentration of rGST in the medium
(18.10 ng/ml) was almost three times higher than with
the human signal (6.10 ng/ml) (Fig. 2A).
For the quantification of intracellular rGST, the crude pro-
tein extracts were directly measured by ELISA (Fig. 2B).
The relation of the values correlated to the extracellular
situation. ASP-GST-transfected protoplasts contained 3.38
ng/ml rGST whereas those transfected with VSP-GST
reached a mean value of no more than 0.35 ng/ml.
For visualisation of recombinant GST on Western blots
(Fig. 2), GST was affinity-purified by using GSH-Sepha-
rose, and the eluted proteins were separated by non-
reducing SDS-PAGE. GST was detected with an anti-GST
antibody. The blots showed the main bands at the
expected size of 26 kDa for the GST protein. The weak
additional higher band was caused by dimer formation.
Weak bands detected in the control lanes may derive from
cross-reactivity of the anti-GST antibody to moss GST or
be an artefact from the protein purification procedure.
Transient production of recombinant human VEGF
To examine whether the supremacy of the moss signal is
specific for GST, we subsequently analysed the secretion
efficiency of ASP and VSP with the hVEGF reporter pro-
tein. When the natural signal peptide was used, the
amount of extracellular rhVEGF ranged between 21.90
and 29.50 ng/ml (mean of 5 transfections: 25.48 ng/ml;
Fig. 3A). Using the moss signal peptide resulted in a more
than fivefold increase of rhVEGF in the culture medium
(mean of 7 transfections: 111.14 ng/ml; single values
ranged from 75 ng/ml to 162 ng/ml). The differences in
extracellular rhVEGF accumulation of ASP-VEGF vs. VSP-
VEGF-transfected cells were also reflected in the Western
analysis (Fig. 3B). Additionally, the amounts of intracellu-
lar rhVEGF were determined by ELISA. ASP-VEGF-trans-
fected protoplasts contained 1.0 ng/ml rhVEGF. Those
transfected with VSP-VEGF reached an average value of
0.51 ng/ml.
Highly efficient secretion by endogenous signal peptides
Comparison of the intracellularly retained and extracellu-
lar proportions of rGST and rhVEGF, respectively, demon-
strates that secretion from the moss cells was very efficient
(Fig. 4). Most of rGST, i.e. 90.6%, was secreted to the cul-
ture medium. Up to 99.8% of the produced rhVEGF accu-
mulated in the culture medium, whereas no significant
amounts were found inside the cells, neither with the
moss signal nor with the human one. Furthermore, the
ratio of intra- to extracellular protein did not differ signif-
icantly between the human and the moss secretion signal.
With respect to the biological processes, we suggest as the
most probable among several possible reasons for the dif-
ference in secretion efficiency a less efficient translation
process when using the human signal (see discussion).
After having proven the high efficiency of one endog-
enous moss signal peptide in the moss system, we aimed
to study the efficiency of additional moss signal sequences
and tested five other putative secretion signals from Phys-
comitrella  in transient transfection assays. These signal
Comparison of heterologous signals from human origin Figure 1
Comparison of heterologous signals from human ori-
gin. The secretion signals of human blood clotting factor IX 
(FSP) as well as human vascular endothelial growth factor 
(VSP) were fused to the coding sequence of vascular 
endothelial growth factor (hVEGF). Moss protoplasts were 
transiently transfected with the expression constructs and 
concentration of extracellular as well as intracellular rhVEGF 
was determined by ELISA. Mean values were taken from 
three transfections. Error bars indicate the absolute average 
deviation (AAD).
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Concentrations of secreted recombinant GST Figure 2
Concentrations of secreted recombinant GST. Physcomitrella protoplasts were transiently transfected with pVSP-GST 
and pASP-GST in eight independent transfections. After 5 days the concentrations of secreted and intracellularly-retained 
recombinant protein were measured by ELISA. Additionally, GST was affinity-purified from both medium and supernatant and 
detected by western blot. A: Culture medium of two transfections was pooled. Mean values of eight transfections are given. B: 
Protoplasts of eight transfections were pooled and GST was affinity-purified from the crude extracts. Values reflect the means 
of the two measurements. Control: mock-transfected protoplasts.
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peptides originated from putative extracellular proteins
isolated from moss culture medium (Tintelnot et al., man-
uscript in preparation). The signal sequences of PpFLP
(fasciclin-like protein), PpLTP (lipid-transfer protein),
PpPME1 (pectin methylesterase), PpXTH1 (xyloglucan
endotransglycosylase/hydrolase), PpCALP (carbonic
anhydrase-like protein) as well as PpAP1 were fused to
rhVEGF in order to analyse their secretion efficiency by
ELISA after transient transfection of moss protoplasts. All
further investigated moss signal peptides showed compa-
rable or even higher secretion efficiencies than the PpAP1
signal ASP (Fig. 5). The rhVEGF amount in the medium
achieved by the signal peptides of PpPME1 and PpXTH1
was approximately 80% higher than with the PpAP1 sig-
nal.
A comparison of the different moss signal peptides is
shown in Fig. 6. According to SignalP, for the six cloned
sequences the probabilities for being a signal peptide were
always higher than 99% and their functionality in vivo was
proven as demonstrated above. All of the signals comprise
many hydrophobic amino acid residues in their central
part indicating the hydrophobic region. The N-terminal
part has at least one positive residue in most of the signals
(except PpCALP and VSP, respectively), whereas the C-ter-
minal part always contains a small and neutral residue at
position -1 and -3 with respect to the cleavage site as it is
proposed for signal sequences [22,23]. The probability for
correct prediction of the cleavage site varied from 58.3%
for PpCALP to 99.8% for PpFLP. High variations were also
found regarding the overall length of the signal sequences,
which ranges from 20 to 27 amino acids. Analysis of avail-
Intra- and extracellular concentrations of recombinant rhVEGF Figure 3
Intra- and extracellular concentrations of recombinant rhVEGF. Physcomitrella protoplasts were transiently trans-
fected with pVSP-VEGF and pASP-VEGF in four (pVSP-VEGF and control) and seven (pASP-VEGF) independent transfections. 
After 5 days the concentrations of secreted and intracellularly retained recombinant protein were measured by ELISA. A: 
mean values of concentrations of extra- and intracellular rhVEGF measured by ELISA. B: Western blot with culture medium of 
transiently rhVEGF-producing cell. Control: untransfected moss protoplasts.
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able Physcomitrella sequences resulted in an average length
of 26 amino acids for 86 signal peptides predicted.
Taken together, the results of the transient production of
recombinant proteins demonstrate that the secretion
machinery of Physcomitrella works very efficiently. Further-
more it was shown that the utilisation of an endogenous
signal peptide can lead to a remarkable increase in recom-
binant protein production in comparison with the heter-
ologous sorting signals used in this study.
Discussion
An important issue in molecular farming is the accumula-
tion and downstream processing of recombinant pro-
teins. Mostly, the proteins are targeted to the secretory
pathway as the complete set of enzymes responsible for
posttranslational modifications, especially for protein gly-
cosylation, is located within the secretory compartments,
i.e. ER and Golgi apparatus. In case of using suspension
cultures as a production system secretion of proteins pro-
vides the additional advantage of easier protein purifica-
tion.
Several systems involving secretion in protein production
have been established. Among these are both, cell suspen-
sion cultures and whole plant systems, e.g. rhizosecretion
[24,25] or production in the water plant Lemna [26]. Seed
storage of the recombinant product also involves secretory
targeting, as deposition in protein storage vacuoles is
achieved by traffic via the secretory pathway [27].
A common practice for the production and secretion of
human proteins in plants is to use their native signal pep-
tide. This is possible because of the conservation of the
signal recognition- and ER-insertion mechanisms
throughout eukaryotes [17,28,29] and circumvents labo-
rious steps of signal engineering. However, the amino-
acid composition of signal peptides is extremely variable
and the exact mechanism of their recognition by SRP and
the translocon is not yet completely understood. Their
determining feature is the hydrophobicity of a ten to fif-
teen residue core sequence, which surprisingly does not
show any sequence conservation [30]. The functionality
of the signals is only marginally impaired by amino-acid
exchanges, as long as the hydrophobic core is not affected
[22,31]. Exchanges within the core can in contrast totally
impede signal recognition, even when leading to a higher
hydrophobicity [32]. A closer look at the nature of the six
moss signal peptides analysed in this study revealed a
high percentage of the hydrophobic amino acids L, F, I, M,
V and W [22] in the central part of the signal peptides,
even though the hydrophobic stretches vary in length and
position. N-terminal of the hydrophobic centre positively
charged residues have been proposed [33]. Except for
PpCALP, all of the moss signal sequence N-termini con-
tain at least one arginine residue. For the signal peptide of
PpCALP, which has no positively charged residue, the ini-
tiation methionine could perhaps compensate the lack of
arginine [34]. All of the investigated signal sequences fol-
low the (-3, -1)rule, which means that the two amino
acids at position one and three previous to the cleavage
site have to be small and neutral [23]. The HMM cleavage
Intra- and extracellular distribution of recombinant protein Figure 4
Intra- and extracellular distribution of recombinant protein. The relations between intra- and extracellular amounts 
of recombinant rhVEGF (A) and GST (B) are given. Values reflect the mean amounts of recombinant protein per transfection. 
ASP: plasmids with moss signal peptide; VSP: plasmids with human signal peptide; extra: amount of recombinant protein in 
culture medium; intra: intracellular amounts of recombinant protein.
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site prediction from SignalP showed a rather low proba-
bility for the signal sequences of PpPME1 (0.684) and of
PpCALP (0.583). Additionally, in case of PpCALP, the Sig-
nalP-neural network predicted a signal peptide length of
32 amino acids instead of 27 amino acids which was pre-
dicted with SignalP-HMM and used in our study. How-
ever, experimental data showed that the sequences for
both PpCALP and PpPME1 were not only functional, but
resulted in a very efficient secretion of the rhVEGF protein.
In addition, cleavage site prediction of ASP and VSP was
verified experimentally. The analysis revealed that secre-
tion dropped drastically when the last amino acid of a cor-
rectly predicted signal was deleted (data not shown).
The average length of eukaryotic signal peptides was cal-
culated to be 22 amino acids [22,35], whereas the average
length of 86 analysed Physcomitrella signal peptides is 26
residues. Although some correlations between the ana-
lysed Physcomitrella signal peptides and other eukaryotic
secretion signals can be found, the variations within the
amino acid composition remain high [34]. A functional
role of additional, most likely structural determinants of
signal peptides is assumed [19].
Previous studies evaluating endogenous vs. heterologous
signal sequences in several species of the plant and animal
kingdoms revealed for the majority a higher efficiency of
kingdom-specific signals [18,36,37]. As secretion is one of
the bottlenecks when establishing a production system,
we aimed to define highly efficient signals to transport the
recombinant proteins to the culture medium of the moss
bioreactor system [16]. Thus we decided to compare six
endogenous moss signal peptides plus two heterologous
sequences from human origin. All of the moss signals
turned out to drive secretion more efficiently than the
human signal peptides. Two signals, the moss-derived
ASP and the human VSP, were analysed in more detail
with two different reporters, rGST (glutathione S-trans-
ferase) and rhVEGF (vascular endothelial growth factor),
respectively. By secretion of the recombinant reporter pro-
tein GST we could show a threefold increase in extracellu-
lar accumulation with the ASP sequence compared to the
human VSP. With the moss secretion signal, extracellular
rhVEGF amount was up to fivefold more. Surprisingly, we
did not find an increased intracellular accumulation in
case of the human signal peptide. Amongst several possi-
ble alternatives (see below), our preferred explanation is
that recognition by the SRP and maybe ER-insertion of the
human signal peptide is suboptimal thus decreasing the
translation rate of the recombinant protein. The differ-
ences in secretion efficiency clearly prove that besides
hydrophobicity, some additional features, that may have
a species-specific character, play a crucial role in signal rec-
ognition. As it is known that SRP occupies the EF-binding-
site of the ribosome and thereby temporarily arrests trans-
lation [38], the cause for a reduced production rate with
the human signal could be found in a hindered dissocia-
tion of SRP after docking of the translation complex to the
translocon.
The second important interaction of the nascent signal
peptide is performed with ER-membrane lipids as well as
the translocon itself [39,40]. This interaction could
demand unknown structural features of a signal peptide,
which are not completely cross-host compatible, as mam-
malian and plant membranes differ significantly in their
lipid composition [41].
However, besides a translational inhibition caused by
hindered SRP-dissociation, alternative explanations for
the worse performance of the human signals do exist: The
protein in part may fail to be properly folded (perhaps
because SP cleavage might not be efficient) and is subse-
quently degraded. Alternatively, transcription of that par-
ticular construct may be inefficient. The only possible
determinant for such events can be found in the relatively
short signal peptide sequences themselves, as all used vec-
tors do not differ in any other detail. Apart from the
above-mentioned translational inhibition, additional
influence of the signal peptide on recombinant protein
stability could only take place during, or shortly after ER-
insertion. When the translation of the protein is com-
pleted, the signal peptides are cleaved. Thereafter, recom-
binant products do not differ in any residue and can
therefore not exhibit different stabilities. Regulatory, post-
targeting functions of cleaved signals are proposed by
Secretion efficiency of different moss signal peptides Figure 5
Secretion efficiency of different moss signal peptides. 
Signal sequences of PpAP1, PpFLP, PpLTP, PpPME1, PpXTH1, 
PpCALP were fused to rhVEGF. Shown are the mean values 
of three independent experiments with three transfections 
each time (n = 9). Prior to calculation of averages, outliers 
were removed if the z-score was >1. RhVEGF concentration 
of the PpAP1-construct was set to 100%. Error bars indicate 
the absolute average deviation (AAD) of the three experi-
ments. Control: untransfected Physcomitrella protoplasts.
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other authors and can therefore not be completely
excluded in our case [42,43].
Conclusion
Even if the structural background remains to be eluci-
dated, our results demonstrate that the six moss sequences
are more efficient than the two human ones used in our
study in promoting secretion of recombinant human
VEGF. In the interplay with optimised gene expression
[44] and product stabilisation [45], the utilisation of
moss-endogenous secretion signals could greatly enhance
the productivity of the moss-bioreactor system.
Methods
Plant material and growth conditions
Physcomitrella patens (Hedw.) B.S.G. was grown axeni-
cally under standard conditions (agitated liquid modified
Knop medium, 250 mg/l KH2PO4, 250 mg/l MgSO4 ×
7H2O, 250 mg/l KCl, 1000 mg/l Ca(NO3)2 × 4H2O, 12.5
mg/l FeSO4 × 7H2O, pH 5.8) in a growth chamber or in
photobioreactors (25 ± 1°C; light provided from outside
by fluorescent tubes, Philips TL-D 36W/25; light flux of 55
µmol s-1 m-2, light-dark regime of 16:8 h) as described
[46].
Prediction of signal sequences
Signal sequences of the putative extracellular Phys-
comitrella proteins Fasciclin-like protein (PpFLP
[EMBL:AJ843251]), Lipid-transfer protein (PpLTP
[EMBL:AJ843246]), Pectin methylesterase1 (PpPME1
[EMBL:AJ843245]), Xyloglucan endotransglycosylase/
hydrolase1 (PpXTH1 [EMBLAJ843248]) and Carbonic
anhydrase-like protein (PpCALP [EMBL:AJ843247]) (Tin-
telnot et al., manuscript in preparation) as well as for
PpAP1 [20] were predicted by SignalP 3.0 Server
[23,33,35].
For analysis of the average length of moss signal peptides,
all 486 publicly available full-length Physcomitrella coding
sequences as of May, 2005 were retrieved from Genbank
and 86 putative signal peptides predicted using the Sig-
nalP 3.0 neural network. In addition, a set of 408 Arabi-
dopsis thaliana coding sequences were retrieved using the
query keywords "mature" and "peptide" and 39 putative
signal peptides predicted.
Construction of targeting vectors
For the construction of pASP-GST and pVSP-GST the cod-
ing sequence (cds) of GST was PCR-amplified with the
primers GSTf (5'-AGATCTATGTCCCCTATACTAGGT-3')
and GSTr (5'-GAGCTCTCACGGAACCAGATCCGATTT-3')
with pGEX (Amersham Biosciences, Germany) serving as
template. The PCR product was directly cloned into the
pCR4-TOPO vector (Invitrogen, Germany). Introduced
BglII and SalI restriction sites enabled the replacement of
the GFP-cds of mAV4 [47] by the newly generated cds for
GST. The resulting plasmid was named pGST. The ASP-
signal was amplified with the primers ASPf (5'-AGATCTT-
GCCTCAGCTAAGGCTGC-3') and ASPr (5'-AGATCTT-
GCCTCAGCTAAGGC-3') using pSP-GFP [20] as template.
The PCR product was directly cloned into pCR4-TOPO
vector. For subcloning in pGST, the introduced SalI and
BglII sites were used. The resulting plasmid was called
pASP-GST.
For the construction of pVSP-GST, the plasmid pVSP-GFP
served as a starting point. It is a derivative of mAV4, with
the cds of the rhVEGF-signal sequence (VSP) fused
Physcomitrella patens signal peptides Figure 6
Physcomitrella patens signal peptides. Amino acid sequences of signal peptides from PpAP1 (ASP), VEGF (VSP) and the 
extracellular proteins PpFLP, PpLTP, PpPME1, PpXTH1, PpCALP, and VEGF are shown as predicted by SignalP. Letters with 
yellow background represent hydrophobic amino acid residues (V, L, I, W, F, M), orange letters positive (K, R) and green let-
ters small and neutral residues (A, C, G, N, P, S, T, V). The predicted cleavage sites are indicated as well as the positions adja-
cent to this site. In the right part of the figure probabilities for each signal peptide and the cleavage site given by the SignalP-
HMM prediction as well as the length of the signal peptides are shown.
Name        Sequence                Probability       Probability         Length  
                    signal pept.     cleav. site          signal pept.
ASP       M MGASRSVRLAFFLVVLVVLAALAEA^SPR    0.999  0.848    25aa 
PpFLP     M MALSSVSRCLVLVLVMLAVVPQAYA^QNC    1.000  0.998    25aa 
PpLTP          M MAQRICIAIVLLLCFSGVSA^QFT    1.000  0.989    20aa 
PpPME1    SMSRCIFSALVILVAVCSVAKPASA^AEF    0.992  0.684    27aa 
PpXTH1  M MGFNRGLQCALPILLLLCCHAMVGSHA^QPV    1.000  0.956    27aa 
PpCALP  M MASQLVQAVAAVVVLQCISASWVGAWA^GSA    0.999  0.583    27aa 
VSP       M MNFLLSWVHWSLALLLYLHAKWSQA^APM    0.992  0.977    20aa  
                                      -3-2-1  +1+2+3 BMC Biotechnology 2005, 5:30 http://www.biomedcentral.com/1472-6750/5/30
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upstream to GFP. The GST-cds was introduced by using
the SalI and BglII restriction sites for replacing the GFP-
cds.
The plasmids pVEGF and pASP-VEGF were constructed
using the plasmids pRT101_C3_VEGF [48] containing the
cds for human VEGF as starting point. The human VEGF
signal was amplified from pRT101_P21 [48] with
MOB_323 (5'-ATACTCGAGGAAGATGAACTTTCTGCT-
GTCTTGG-3') and MOB_349 (5'-CTGCCATGGGT-
GCAGCCTGGGACCAC-3') and cut at XhoI/NcoI
restriction sites for ligation into pRT101_C3_VEGF. The
ASP-signal from Physcomitrella patens (PpAP1) located on
the plasmid pSP-GFP was amplified using MOB_642 (5'-
GCCCTCGAGGAAGATGGGGGCATCGAGGAGT-3') and
MOB_765 (5'-CTGCCATGGGTGCTGCCT-
CAGCTAAGGC-3'). By use of the restriction sites XhoI
and NcoI the was cloned into pRT101_C3_VEGF.
Construction of the plasmid pUC-SP-VEGF was carried
out by replacing the luciferase-cds and terminator in pluc-
Actin [44] with the cds of rhVEGF and 35S-terminator
from pAP1-SP-VEGF-His [15] via the enzymes Hind III
and Nco I. The different secretion signals – plus four base-
pairs (GCAC) missing from the rhVEGF cds after Nco I
digest – were cloned into the pUC-SP-VEGF via the restric-
tion enzymes Nco I and Xho I after PCR amplification and
direct cloning into the pCR4-TOPO vector (Invitrogen).
The following primers were used for amplification: PME-
SPf (5'-CGAGCGCAATGGGGAGCATGTC-3') and PME-
SPr (5'-TCCATGGGTGCTGCTGACGCGGGCTTC-3'),
XTH-SPf (5'-GCTGCAGAGAAATGGGGTTCAATAGAGG-
3') and XTH-SPr (5'-TCCATGGGTGCAGCGTGACT-
GCCGAC-3'), CALP-SPf (5'-GCTCGAGGGCGAT-
GGCGAGCCAACTTG-3') and CALP-SPr (5'-
TCCATGGGTGCTGCCCACGCGCCAAC-3'), FLP-SPf (5'-
GCTCGAGAACAATGGCGCTTTCGTCGG-3') and FLP-SPr
(5'-TCCATGGGTGCGGCATACGCTTGAGGC-3'), GLP-
SPf (5'-GCTCGAGTAACATGGCTGCCCGTTTCG-3') and
GLP-SPr (5'-TCCATGGGTGCAGCATACACCATGGCC-
3'), LTP-SPf (5'-GCTCGAGGAGGATGGCACAACG-
CATTTG-3') and LTP-SPr (5'-TCCATGGGTGCAGCA-
GACACTCCAGAG-3'), and AP-SPf (5'-
TCTCGAGGACGATGGGGGCATCGAGGAG-3') and AP-
SPr (5'-TCCATGGGTGCTGCCTCAGCTAAGGCTG-3') for
the endogenous signal peptides as well as VEGF-SPfor (5'-
TGCTCGAGCGAGATGAACTTTCTGCTGTC-3') and rev
(5'-TTCCATGGGTGCAGCCTGGGACCACTTG-3') for the
heterologous secretion signal.
Transfection of Physcomitrella protoplasts
The DNA for transfection was prepared with Qiagen's
Plasmid Maxi kit. A total number of 3 × 105 protoplasts
was transiently transfected with 30–50 µg of circular plas-
mid DNA. Protoplasts were isolated from bioreactor-
grown material and transfected as described [46]. After
transfection, the protoplasts were suspended in 100 µl 3
M-medium supplemented with 0.01% BSA and subse-
quently transferred to 96 well plates (Nunclon™ surface;
Nunc, Denmark). After 24 hrs the culture medium was
replaced with fresh medium. Five days after transfection
the supernatant was harvested. Protoplasts were resus-
pended in 100 µl PBS buffer supplemented with 1% Tri-
ton X100 and 1% plant protease inhibitor cocktail
(Sigma, Germany). These samples were immediately
processed with protein extraction.
Extraction of intracellular protein
For the extraction of intracellular protein, glass beads (1
mm diameter) were added to the tubes. Cell disruption
was carried out in a beadmill (Tissuelyzer, Qiagen) for 1
min at 30 Hz. Cell debris was sedimented (14,000 rpm,
10 min, 4°C) and the supernatant was transferred into a
fresh tube for further assaying.
Measurement of protein concentration by ELISA
Extra- and intracellular concentrations of recombinant
protein were determined by ELISA. In order to adjust pH
and ionic conditions, the harvested culture medium was
supplemented with an equal volume of 2 × PBS and kept
on ice until ELISA measurement or stored at -80°C. Cell
extracts were directly applied to the ELISA. All samples
were diluted appropriately and measured in duplicates.
Separate standard dilutions were prepared for medium-
and cell extract-conditions respectively, because of the
samples' different buffer conditions. For determination of
recombinant GST concentrations, the 96 well detection
module (Amersham Biosciences) was used following the
manufacturer's instructions. Recombinant hVEGF sam-
ples were analysed by sandwich ELISA (anti-hVEGF, cap-
ture: #AF-293-NA, anti-hVEGF, detection: #BAF-293,
rhVEGF121, standard: #298-VS, R&D, Germany; Nunc-
Immunosorb plates). Dilutions were made in 1 × PBS/
0.1% BSA (Serva, Germany).
Purification of GST
Recombinant GST was affinity-purified using GSH-Sepha-
rose (Gluthathione Sepharose 4B, Amersham Bio-
sciences). Therefore a 50%-slurry of the GSH-Sepharose
was prepared according to the manufacturer's instructions
and 1/50 volume of the slurry was added to the protein
solution. In case of extracellular GST, 1/10 volume of 10
× PBS buffer was added to adjust pH of the culture
medium. Binding was carried out for 2 hours at room
temperature with gentle end-over-end rotation. GSH-
Sepharose was sedimented at 500 × g for five minutes and
the supernatant was discarded. The sepharose was washed
once with ten bed volumes of PBS buffer. After adding 50
µl of SDS sample buffer, the samples were heated at 95°C
for five minutes, and centrifuged for one minute at 13,000BMC Biotechnology 2005, 5:30 http://www.biomedcentral.com/1472-6750/5/30
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× g. The resulting supernatant was analysed by SDS-PAGE
followed by Western blot.
SDS-PAGE and western blot
For the visualisation by Western blot, the affinity-purified
GST was first separated on a 12% SDS gel following stand-
ard techniques. The separated proteins were then trans-
ferred to a PVDF membrane (Immobilon-P, Millipore,
Germany) with the semi-dry method. Transfer was carried
out according to the instructions given by the membranes
manufacturer. For signal detection, the ECL advance west-
ern blotting detection kit (Amersham Biosciences) was
used. All steps were carried out according to the manufac-
turer's protocol. Anti-GST antibody (developed in rabbit,
Sigma) was used at a 1:5,000 dilution. Anti-rabbit anti-
body (peroxidase-coupled, developed in donkey, Amer-
sham Biosciences) was used for detection in a 1:500,000
dilution. For rhVEGF, anti-human VEGF (#AF-293-NA,
1:500), anti-goat IgG (#A5420, Sigma, 1:8000) and
rhVEGF as standard was used.
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